Results of General Meeting & Open Offer

RNS Number : 1528S
Inspiration Healthcare Group PLC
06 July 2020
 

6 July 2020

 

Inspiration Healthcare Group plc

 

("Inspiration Healthcare" the "Group" or the "Company")

 

Results of General Meeting & Open Offer

Inspiration Healthcare Group plc (AIM:IHC), the global medical technology company, is pleased to announce that at the General Meeting held earlier today, all resolutions proposed were duly passed by shareholders. Details of the votes cast by proxy will be published on the Company's website shortly.

 

Furthermore, the Open Offer, which closed for acceptances at 11.00 a.m. on 3 July 2020 was oversubscribed, with final valid applications from Qualifying Shareholders in respect of 909,757 Open Offer Shares including applications under the Excess Application Facility, representing a take-up of approximately 118.5 per cent. of the Open Offer Shares. Qualifying Shareholders have been scaled back on a pro rata basis, such that the maximum number of Open Offer Shares of 767,617 have been issued.

 

Accordingly, the Company will raise a total of approximately £17.0 million (before expenses) through the Placing, Subscription and Open Offer . An application has been made for the 28,921,463 new Ordinary Shares being the Placing Shares, the Subscription Shares, the Open Offer Shares and the Consideration Shares to be admitted to trading on AIM, which is expected to take place at 8.00 a.m. on 7 July 2020.

Following Admission, the Company's issued share capital will comprise 67,973,609 Ordinary Shares, of which none are held in treasury. The above figure of 67,973,609 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the voting rights of the Company under the FCA's Disclosure Guidance and Transparency Rules.

Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meanings as defined in the circular sent to shareholders of the Company on 19 June 2020.

Enquiries:

Inspiration Healthcare Group plc

Neil Campbell, Chief Executive Officer

Jon Ballard, Chief Financial Officer

Tel: 01455 840555

 

Nominated Adviser & Broker

Cenkos Securities plc

Mark Connelly

Stephen Keys

Cameron MacRitchie

Tel: 0207 397 8900

 

Cadogan PR 

Alex Walters

alex.walters@cadoganpr.com

Tel: 07771 713608

 

About Inspiration Healthcare   http://www.inspiration-healthcare.com

Inspiration Healthcare is a global provider of medical technology for use in critical care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.

Through investment in research and development the Company has 6 key own brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with assessment, resuscitation, stabilisation as well as preventing brain damage. Additionally the Company has its own range of products for maintaining normothermia pre- during and post-surgery.

With product availability extending to over 50 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe. In the UK and Ireland the Company has a direct sales team selling Inspiration Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance. Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROMGZGGNZVVGGZM
UK 100

Latest directors dealings